Edition:
India

Carl Zeiss Meditec AG (AFXG.DE)

AFXG.DE on Xetra

46.83EUR
17 Nov 2017
Change (% chg)

€-0.19 (-0.41%)
Prev Close
€47.03
Open
€47.03
Day's High
€47.15
Day's Low
€46.80
Volume
54,107
Avg. Vol
85,906
52-wk High
€48.90
52-wk Low
€30.80

Chart for

About

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and... (more)

Overall

Beta: 0.42
Market Cap(Mil.): €4,114.27
Shares Outstanding(Mil.): 89.44
Dividend: 0.42
Yield (%): 0.91

Financials

BRIEF-Carl Zeiss Meditec: ‍acquisition of Veracity Innovations​

* ‍ACQUISITION OF VERACITY INNOVATIONS, LLC​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

21 Aug 2017

Valeant in talks to sell eye-surgery assets to Carl Zeiss: Bloomberg

Canadian drugmaker Valeant Pharmaceuticals International Inc  is in talks to sell its Bausch & Lomb unit's surgical products business to Germany's Carl Zeiss Meditec AG , Bloomberg reported.

06 Jun 2017

UPDATE 1-Valeant in talks to sell eye-surgery assets to Carl Zeiss - Bbg

June 6 Canadian drugmaker Valeant Pharmaceuticals International Inc is in talks to sell its Bausch & Lomb unit's surgical products business to Germany's Carl Zeiss Meditec AG, Bloomberg reported.

06 Jun 2017

Valeant in talks to sell eye surgical products business - Bbg

June 6 Canadian drugmaker Valeant Pharmaceuticals International Inc is in talks to sell its Bausch & Lomb unit's surgical products business to Germany's Carl Zeiss Meditec AG, Bloomberg reported.

06 Jun 2017

German stocks - Factors to watch on May 30

FRANKFURT, May 30 The DAX top-30 index looked set to open 0.1 percent lower on Tuesday, according to premarket data from brokerage Lang & Schwarz at 0607 GMT.

30 May 2017

Earnings vs. Estimates